| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.981 | 40.734 | 49.689 | 20.976 | 11.925 | 9.691 | 17.387 | 23.851 | 14.835 | 3.005 |
| Total Income - EUR | 14.432 | 40.896 | 51.664 | 23.558 | 16.777 | 12.752 | 19.097 | 23.866 | 15.141 | 3.328 |
| Total Expenses - EUR | 6.465 | 10.299 | 11.637 | 6.817 | 9.521 | 6.359 | 6.370 | 4.096 | 9.325 | 3.327 |
| Gross Profit/Loss - EUR | 7.967 | 30.597 | 40.028 | 16.742 | 7.256 | 6.392 | 12.728 | 19.770 | 5.816 | 2 |
| Net Profit/Loss - EUR | 7.534 | 30.072 | 39.530 | 16.529 | 7.128 | 6.329 | 12.571 | 19.068 | 5.667 | 1 |
| Employees | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ana Ene Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 930 | 698 | 474 | 258 | 51 | 0 | 0 | 0 |
| Current Assets | 172.234 | 133.933 | 140.364 | 154.372 | 158.751 | 102.063 | 106.078 | 113.578 | 100.315 | 98.492 |
| Inventories | 129 | 146 | 143 | 336 | 330 | 324 | 203 | 290 | 0 | 959 |
| Receivables | 97.705 | 98.826 | 95.619 | 92.992 | 91.191 | 89.958 | 87.115 | 101.782 | 87.120 | 86.633 |
| Cash | 74.400 | 34.961 | 44.602 | 61.043 | 67.230 | 11.782 | 18.760 | 11.506 | 13.195 | 10.900 |
| Shareholders Funds | 171.752 | 132.946 | 140.663 | 154.611 | 158.744 | 101.837 | 105.961 | 112.749 | 99.063 | 98.511 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 483 | 987 | 632 | 460 | 481 | 484 | 167 | 829 | 1.252 | 38 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ana Ene Med Srl